Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial-Reference-Cited by-同舟云学术

Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial

Published:2019-05-17 Issue:2 Volume:370 Page:197-205
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Minotti Giorgio,Menna Pierantonio,Calabrese Vito,Greco Carlo,Armento Grazia,Annibali Ombretta,Marchesi Francesco,Salvatorelli Emanuela,Reggiardo Giorgio

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer

2. Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties

3. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

4. Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer

5. Sildenafil and B-Type Natriuretic Peptide Acutely Phosphorylate Titin and Improve Diastolic Distensibility In Vivo

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold story;Progress in Cardiovascular Diseases;2024-07

2. The Role of Ranolazine in Heart Failure-Current Concepts;The American Journal of Cardiology;2023-12

3. Efficacy of Ranolazine to Improve Diastolic Performance in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis;European Cardiology Review;2023-01-21

4. Comment on the ESC Guidelines 2022 for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death;European Cardiology Review;2023-01-20

5. Cardiovascular Effects of Ranolazine and the Scope for Translational Research: A Current Review of Literature;Frontiers in Cardiovascular Drug Discovery;2022-11-09